#Autoinflammation
Truncating variants reveal functional divergence of the SAMD9 and SAMD9L paralogues. New study from Petar Mitev, Yenan T. Bryceson @ki.se and collagues:
rupress.org/jhi/article/...

#Autoinflammation #Diagnostics
November 17, 2026 at 3:15 PM
Familial #TLR8 gain-of-function presenting as HLH with response to IFN-γ blockade. New study from John S. Barber, Talal Mousallem @dukehealth.bsky.social and colleagues:
rupress.org/jhi/article/...

@macattacklab.bsky.social
#Autoinflammation #InbornErrorsOfImmunity
November 17, 2026 at 9:30 PM
Mitev, Bryceson @ki.se et al. characterize novel patient-derived SAMD9 and SAMD9L variants, including the SAMD9L p.C883X truncation, which prompted systematic investigation of homologous SAMD9 truncations & uncovered unexpected functional divergence rupress.org/jhi/article/...

#Autoinflammation
November 10, 2026 at 5:45 PM
RRIDs were included in this in JCI Insight paper. We value the author's support of reproducibility. #STMpublishing #reproducibility #OpenScience
Truncating RELA variants drive autoinflammation and autoimmunity by impairing the negative feedback control of NF-κB
Read the full paper: Truncating RELA variants drive autoinflammation and autoimmunity by impairing the negative feedback control of NF-κB
doi.org
November 8, 2026 at 8:02 AM
Cells must distinguish cellular-derived RNA from pathogenic RNA to mount antiviral responses while avoiding autoinflammation. A new #OpenBiology review describes our current understanding of how cells achieve self-tolerance through the active regulation of endogenous RNA: doi.org/10.1098/rsob...
November 5, 2026 at 1:02 PM
NFKB1 truncation–associated recurrent, sterile #inflammation effectively treated with IL-1β blockade. New study from Kevin S. Ackerman, Isabel F. Armendi, Jay J. Mehta, and Neil Romberg @romberglab.bsky.social @childrensphila.bsky.social
rupress.org/jhi/article/...

#Autoinflammation
October 30, 2026 at 1:45 PM
What a week at #ESID2026 in Maastricht! I presented our somatic CBL deficiency story (out in Nature Immunology), and Ivan, Marta & Taja presented posters on their projects. Huge congrats to Taja, who won a Best e-Poster Award for her work on tRNA-driven autoinflammation! 🏆
October 29, 2026 at 12:58 PM
autoinflammatorischen Syndromen beteiligt. Allerdings wird bei Autoinflammation auch ein nicht-kanonisches Caspase-1 Signaling beobachtet, da wäre das NLRP3 Inflammasome nur indirekt beteiligt. Alles Grund genug, sich bei MECFS die Signalpfade rund um das NLRP3 Inflammasome genauer anzuschauen.
October 25, 2026 at 8:26 AM
New work involving mice and patient cells reveals the mechanisms behind how neutrophils drive a rare group of autoinflammatory disorders called CAPS—and uncovers a potential new therapeutic target. #ScienceSignaling https://scim.ag/4zCDwcO
Clusters of GSDMD and GSDME mediate neutrophil pyroptosis in cryopyrin-associated periodic syndrome
Gasdermins D and E cooperatively promote pyroptosis in a neutrophil-driven autoinflammation syndrome.
scim.ag
October 21, 2026 at 10:32 PM
autoinflammation
October 18, 2026 at 3:29 AM
Clusters of GSDMD and GSDME mediate neutrophil pyroptosis in cryopyrin-associated periodic syndrome | Science Signaling www.science.org/doi/10.1126/...
Clusters of GSDMD and GSDME mediate neutrophil pyroptosis in cryopyrin-associated periodic syndrome
Gasdermins D and E cooperatively promote pyroptosis in a neutrophil-driven autoinflammation syndrome.
www.science.org
October 16, 2026 at 1:35 PM
New work involving mice and patient cells reveals the mechanisms behind how neutrophils drive a rare group of autoinflammatory disorders called CAPS—and uncovers a potential new therapeutic target.

Read more in Science Signaling: scim.ag/3Wrz4yX
Clusters of GSDMD and GSDME mediate neutrophil pyroptosis in cryopyrin-associated periodic syndrome
Gasdermins D and E cooperatively promote pyroptosis in a neutrophil-driven autoinflammation syndrome.
scim.ag
October 15, 2026 at 4:01 PM
☀️ Day 2 of #ESID2026 is here!
A new day of science, discussion and discovery awaits in Maastricht.

Today’s programme takes us from immune metabolism and genetics to diagnostics, autoinflammation and cell and gene therapy, bringing new approaches to IEI care.

Ready for another day of #ESID2026?
October 15, 2026 at 8:44 AM
1. New research published in 𝘚𝘤𝘪𝘦𝘯𝘤𝘦 𝘈𝘥𝘷𝘢𝘯𝘤𝘦𝘴 by senior author Dr. David Bilder demonstrating a mechanism that can be exploited by tumors to reduce immune responses in Drosophila, promoting tumor progression and host mortality.

Dr. Bilder is a Discovery Boost grantee.

doi.org/10.1126/scia...
Macrophage restriction in Drosophila wounds and tumors via a matrix degradation–moderating protease inhibitor
Breaches of epithelial homeostasis trigger an inflammatory response. Not only initiation but also negative regulation of the response is critical, as autoinflammation can cause tissue damage and chron...
doi.org
October 10, 2026 at 6:14 PM
A fatal case of #Aspergillus #endocarditis in a pediatric patient with STING-associated vasculopathy. New report from Ambre Dethier, Bénédicte Neven @upcite.bsky.social et al.:
rupress.org/jhi/article/...

#InfectiousDiseases #PopulationGenetics #InbornErrorsOfImmunity #Autoinflammation #SAVI
September 29, 2026 at 1:15 PM
Macrophage restriction in Drosophila wounds and tumors via a matrix degradation–moderating protease inhibitor
Science Advances
www.science.org/doi/10.1126/...
Macrophage restriction in Drosophila wounds and tumors via a matrix degradation–moderating protease inhibitor
Breaches of epithelial homeostasis trigger an inflammatory response. Not only initiation but also negative regulation of the response is critical, as autoinflammation can cause tissue damage and chron...
www.science.org
September 28, 2026 at 6:33 AM
腫瘍は炎症ブレーキを乗っ取る

腫瘍が細胞外基質の分解を抑制する因子を出すことで、腫瘍自身がマクロファージによって攻撃されづらくなる仕組みを持っていることを発見。ハエの系。ヒトでもCD109分子とも共通点があり抗がん治療のヒントになるかも

面白いです!
www.science.org/doi/10.1126/...
Macrophage restriction in Drosophila wounds and tumors via a matrix degradation–moderating protease inhibitor
Breaches of epithelial homeostasis trigger an inflammatory response. Not only initiation but also negative regulation of the response is critical, as autoinflammation can cause tissue damage and…
www.science.org
September 27, 2026 at 10:00 AM
Skin biopsy in adult-onset Still's disease: A specific, rapid, and widely available diagnostic test. New study by Derrick H.Y. Chong, Luke Y.C. Chen (University of British Columbia) and colleagues:
rupress.org/jhi/article/...

#Autoinflammation #cytokines #AOSD
September 25, 2026 at 8:01 PM
📢 Save the date : 16 octobre 2026 - 2ème journée des Centres de compétence maladies rares RAISE.

📝 Inscription gratuite obligatoire avant le 1er octobre.
🔗 www.reso-bordeaux.fr/2eme-journee...

#MaladiesRares #AutoImmunité #AutoInflammation
September 15, 2026 at 12:17 PM
Falls also wer in meiner bubble Immunolog:innen oder welche aus verwandten Forschungsbereichen kennt, bitte weiterleiten.
Übrigens: Soweit ich das verstehe, sind Autoinflammation (innate) und Autoimmunität (adaptive) unterschiedlich intensiv bei ME/CFS vertreten. Insgesamt ist das adaptive
September 11, 2026 at 8:34 AM
Opioid-Rezeptor-Antagonist ist, ist das alles ein wenig überraschend, aber mittlerweile doch ziemlich gut empirisch belegt. Insgesamt wird damit also die Autoinflammation (Autoimmunität des angeborenen Immunsystems) ganz gut adressiert. Soweit eigentlich klar und nicht ganz neu,
September 11, 2026 at 8:34 AM
This is a super interesting (IMO) study on how T cells can repress out of control B cell responses, particularly relevant to autoimmunity and lymphomagenesis #Immunosky #lymphomasky
www.cell.com/immunity/ful...
Hyperreactive B cells instruct their elimination by T cells to curb autoinflammation and lymphomagenesis
Aberrant immune signal strength in B cells is associated with autoimmune diseases and lymphoma. Diehl et al. show that hyperreactive B cells trigger cytotoxic T cell-mediated elimination. Less reactiv...
www.cell.com
January 16, 2025 at 7:24 PM
Today,I appointed Jürgen Rech as #FAUprof. Jürgen is based at Medical Clinic 3 – Rheumatology and Immunology at our university hospital. His research focuses on autoinflammation, fever syndromes, post-COVID, and early-stage rheumatoid arthritis, aiming to potentially prevent its development. @fau.de
February 27, 2025 at 9:29 AM